Company performance
Add to research
Current Price
as of Mar 20, 2025$3.04
P/E Ratio
N/A
Market Cap
$387.1M
Description
Add to research
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.
Metrics
Add to research
Overview
- HQVancouver, WA
- SectorHealth Technology
- IndustryBiotechnology
- TickerABSI
- Price$3.04+2.01%
Trading Information
- Market cap$387.10M
- Float80.85%
- Average Daily Volume (1m)4,402,361
- Average Daily Volume (3m)5,645,377
- EPS-$0.94
Company
- Revenue$4.53M
- Rev growth (1yr)-20.71%
- Net income-$103.11M
- Gross margin-195.30%
- EBITDA margin-2,106.29%
- EBITDA-$95.50M
- EV$170.56M
- EV/Revenue37.62
- P/EN/A
- P/S73.91
- P/B1.96
- Debt/Equity5.64
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset